Delivery Order SPE2DB22D1106-SPE2DB25FEGW3
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,662.56 to AmerisourceBergen Drug Corp for phenazopyridine hydrochloride on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 200 mg tablets (100 count) under a firm fixed-price contract valued at $2,463.42, with an ultimate completion date of August 7, 2025. This non-set-aside award was issued on August 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 200 mg tablets in quantities of 100 units, with a ceiling value of $4,995.56. This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of October 22, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. Performance of this delivery...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $2,078.96 to supply Phenazopyridine 200 mg tablets in quantities of 100 units. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. This delivery order was executed without a set-aside designation and will be performed at the awardee's...
- This federal contract award, with ID SPE2DB22D3102|SPE2DB24FL0DA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.71 firm fixed-price delivery order is for the supply of 4,563,744,487 units of the medication Phenazopyridine 100 mg tablets. The contract has an ultimate completion date of February 23, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $513.54 to Amerisourcebergen Drug Corp for the supply of 200mg phenazopyridine tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver 100 count bottles of the medication to a location in Conshohocken, Pennsylvania by July 27, 2023 to fulfill the agency's requirements. The Defense Logistics Agency is a combat support agency under the Department of Defense responsible for worldwide logistics...
- The Defense Logistics Agency awarded a $1,222.86 delivery order to AmerisourceBergen Drug Corp for Pyridium 200 mg tablets (100-count units) on June 18, 2025, with a completion date of June 20, 2025. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,551.96 to AmerisourceBergen Drug Corp for Phenohytro tablets (100s) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies totaling $166,096.12 under a firm fixed-price contract. The award, issued on September 29, 2025, covers delivery of Myrbetriq ER 50 mg tablets (90-count units) with an ultimate completion date of September 30, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Pioglitazone HCL 45 mg tablets (500 count) with a contract ceiling value of $3,637.83 and an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEGW3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.15 to AmerisourceBergen Drug Corp on April 8, 2025, for the supply of Phenazopyridine 200 mg tablets in quantities of 100. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed by April 9, 2025, and is based at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal portfolio includes generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic categories. The underlying SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for Phenazopyridine, a urinary analgesic medication commonly used in military and federal healthcare systems, exemplifies the routine pharmaceutical fulfillment conducted under this major contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/8/25 |